A federal lawsuit is accusing three of the biggest drug manufacturers of insulin of conspiring together to raise their prices, but the pharmaceutical companies deny the allegations. The lawsuit, filed on in January in a federal court in Massachusetts, said Sanofi SA, Novo Nordisk and Eli Lilly & Co simultaneously hiked the price of the drug. Investment research firm SSR Health analyzed list …
More than 29 million Americans live with diabetes, and for some six million of them, insulin is a life or death medication. Between 2002 and 2013, the price of insulin more than tripled, to more than $700 per patient. A federal lawsuit accuses the three insulin manufacturers of conspiring to raise their prices.
A Stamford lawyer has filed a class-action lawsuit against Griffin Hospital in Derby on behalf of more than 3,100 former patients who may face HIV or other blood-borne diseases as a result of hospital employees using the same insulin injection pens on patient after patient.